Aera Therapeutics
PrivateLast Round
Series A
and B
Feb 16, 2023
Total Funding Raised
$193M
Company Overview
Aera Therapeutics is a biotechnology company that develops proprietary delivery platforms, including protein nanoparticles, lipid nanoparticles, and antibody-oligonucleotide conjugates, to enable transformative genetic medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aera Therapeutics Comparables
Compare Aera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stylus Medicine | 89% | |
| Velvet Therapeutics | 85% | |
| Alaya.bio | 84% | |
Aera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A and B | Feb 16, 2023 |
Key People
Founding team and executive leadership
Aera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series A and B |
| ARCH Venture Partners | Series A and B |
| Lux Capital | Series A and B |
| ARCH Venture Partners | Series A and B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2025
Presented data on AERA-109, a targeted In Vivo CAR-T therapy.
- Dec 2, 2025
Presenting preclinical data at the 67th ASH Annual Meeting.
Aera Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aera Therapeutics's valuation, stock price, and market status.